Journal
CURRENT MEDICINAL CHEMISTRY
Volume 29, Issue 24, Pages 4202-4215Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867328666211125092438
Keywords
D-serine; D-aspartate; early diagnosis; Alzheimer's disease; schizophrenia; pancreatic cancer; chronic kidney diseases
Funding
- Ministero Universita e Ricerca Scientifica PRIN [2017H4J3AS]
Ask authors/readers for more resources
D-amino acids, present in the human body from various sources, play important roles in physiological processes and are increasingly linked to different pathological states. Determining their levels in blood can serve as diagnostic and prognostic biomarkers for multiple disorders, including neurological and psychiatric conditions. Further studies are necessary to standardize and confirm the clinical effectiveness of these measurements.
Background: D-amino acids are present in the human body originating from diet, bacterial flora, and endogenous synthesis (at least for D-serine and, probably, D-aspartate). D-amino acids are involved in important physiological processes (e.g., D-serine and D-aspartate act on the N-methyl-D-aspartate receptor as co-agonist and agonist, respectively) and increasing evidence links D-amino acids to different pathological states. Methods: Determination of D-amino acids levels in blood is mainly based on enantiomeric separations by high performance liquid chromatography. Because of the low amount of D-enantiomers compared to the corresponding L-amino acids and the high background noise associated with biological matrices, positive and negative controls are absolutely required to obtain reliable values. Results: Altered levels of D-serine in blood have been reported in several neurological and psychiatric disorders: it has been proposed as promising biomarker in schizophrenia, Alzheimer's disease, and amyotrophic lateral sclerosis. Indeed, D-serine levels seem an appropriate predictor of anti-depressant response in major depressive disorder and post- traumatic stress disorder, as well as a prognostic biomarker of early cognitive decline, especially when considering D-serine and D-proline levels simultaneously. Furthermore, D-amino acids seem useful biomarkers for pathologies not related to the central nervous system, such as pancreatic cancer and chronic kidney diseases. Conclusion: This is the first review focusing on the determination of blood levels of D-amino acids as diagnostic and prognostic biomarkers. The experimental evidence of involvement of D-amino acids in various physiological pathways suggest investigating their levels in additional pathologies too, such as diabetes mellitus. In conclusion, the levels of D-amino acids in blood may represent novel diagnostic peripheral biomarkers for various disorders. Further studies are required to standardize/automatize the determinations and for confirming their clinical effectiveness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available